According to FMI’s report, the asia pacific reprocessed medical devices industry is expected to grow at a 14.4% CAGR over the projected period. In 2023, it is anticipated that the industry would grow to a market size of US$ 428.4 million. The market is anticipated to generate US$ 1,639.4 million by 2033.
Japan, which attained the largest market share historically, is anticipated to lead the Asia Pacific market for reprocessed medical devices. This trend is expected to persist during the projection period due to rising usage and significant unmet medical need in Japan.
A rising emphasis on reducing medical waste is anticipated to be a major market driver in the Asia Pacific region. For instance, according to estimates from the National Bureau of estimates of China, more than two million tonnes of medical waste were produced in China in 2018.
Request A Report Sample To Gain Comprehensive Insights! https://www.futuremarketinsights.com/reports/sample/rep-ap-3211
Deployment of reprocessed medical devices results in substantial savings in the healthcare sector, which is fueling the demand for these devices.
The lowered pricing of these products is projected to create lucrative growth prospects for market leaders. Consumers present in China, India, Malaysia, and Indonesia are price-sensitive. Within these countries, reprocessed medical devices are retailed at about 50% of the price of a new device. As a result, medical devices with appropriate regulatory approval and low price are being adopted at a faster pace.
The invigorating distribution network is also fueling the market for reprocessed medical devices in the Asia Pacific region. Additionally, increasing focus on investment in the region by the manufacturers of reprocessed medical devices is projected to further the market development.
Top Highlights from the FMI’s Analysis of the Asia Pacific Reprocessed Medical Devices Market:
- Japan acquired a 29.4% market share of the Asia Pacific reprocessed medical devices in 2022. The country is projected to account for 11.9% CAGR over the forecast period.
- China follows Japan as the leader in the Asia Pacific market for reprocessed medical devices in 2022, by acquiring an 18.9% value share in 2022.
- South East Asia gained a 15.3% value share in 2022. South East Asia is projected to register CAGR of 14.8% in the forecast period.
- India had the piece of 12.5% market share in the Asia Pacific reprocessed medical devices in the year 2022.
- Australia had an 11.7% market share in 2022. The country is expected to expand at a CAGR of 14.2% over the upcoming years.
- New Zealand had a 2.8% value share in 2022. The country is projected to thrive at 12.9% CAGR over the forecast period.
- China and India are enjoying the most amount of growth in the market, expanding at 18.8% and 18% CAGRs, respectively.
- Based on devices, cardiology devices gained a market share of 59.2% value share in 2022.
- Based on the classification, the semi-critical segment acquired 46.17% market share in 2022.
- Under the reprocessing methods category, third party assisted section gained a 47.51% value share in 2022.
- Based on end users, the hospitals segment acquired 53.64% market share in 2022.
Feel Free To Reach Out To Our Analyst For Any Queries You Might Have! https://www.futuremarketinsights.com/ask-question/rep-ap-3211
Innovation Watch: Key Developments in the Market
- Johnson & Johnson Services, Inc. officially declared that DePuy Synthes got the 510(k) clearance from the United States FDA for ATTUNE Total Knee System in January 2021. This VELYS Robotic-facilitated Solution also has clear indications for use. The sales of the product are projected to increase in the present as well as future to meet the surging demand in the market.
- Olympus Corporation unveiled that it introduced the OERElite Automatic Endoscope Reprocessor (AER) in October 2020. The product is designed to deploy AcecideC to clean and sterilize up to two endoscopes concurrently in 28 minutes.
- Cleanpart GmbH launched a quality management system for healthcare devices in April 2020.
Key Players:
- Stryker Sustainability Solutions, Inc.
- Medline ReNewal
- Hygia Health Services, Inc.
- Cleanpart GmbH
- ReNu Medical, Inc.
- SureTek Medical
- NEScientific
- Others
Customize Your Report: Tailor the Exclusive Insights to Your Asia Pacific Reprocessed Medical Devices Market Strategy! https://www.futuremarketinsights.com/customization-available/rep-ap-3211
Key Segments in Asia Pacific Reprocessed Medical Devices Market are as follows:
By Product Type:
- Gastroenterology Devices
- Cardiology Devices
- Laparoscopy Devices
- Orthopaedic/Arthroscopic Devices
- ENT Devices
- Others
- Pulse Oximetry Sensors
- Ultrasound Catheters
By Classification:
- Critical
- Semi-critical
- Non-critical
By Reprocessing Method:
- In House
- Third-party Assisted
- Non-compliant Reprocessors
By End User:
- Hospitals
- Diagnostic Centres
- Ambulatory Surgical Centres
By Country:
- Australia
- New Zealand
- China
- India
- South East Asia
- Japan
- Rest of Asia Pacific
Gain Immediate Access to Detailed Market Insights: Purchase Now! https://www.futuremarketinsights.com/checkout/3211
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
